Ipilimumab, an antibody that blocks cytotoxic T-lymphocyte antigen-4 (CTLA-4), an inhibitory molecule present on activated T cells, is used to treat patients with metastatic melanoma [115]. The gene discussed is CTLA4; the disease is metastatic melanoma.